Published in TB and Outbreaks Week, August 25th, 2009
"The company is in discussions with a global leader in the health care sector to arrange distribution following our regulatory approval," said Stephen J. Browand, CEO BioNeutral Group Inc. "Our health care market alone is very...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.